Skip to main content
· 10/29/2003

Asahi Glass Co., Ltd. v. Pentech Pharmaceuticals

Citations

  • 289 F. Supp. 2d 986
  • 2003 U.S. Dist. LEXIS 19370
  • 2003 WL 22462405

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • applying the scope-of-the patent test; “there is no doubt that the patent may well be valid, so that Glaxo cannot be faulted for trying to enforce it.”
  • “If any settlement agreement is thus to be classified as involving a forbidden ‘reverse payment’ we shall have no more patent settlements.”
  • the competitor could use the provided product to undersell the brand manufacturer
  • “The claim of fraud on the patent office fails for the reason just given: if patent 723 was obtained by fraud, it was a fraud aimed at competing manufacturers of drugs, not at the suppliers of those manufacturers, and so the fraud claim cannot be pressed as an antitrust claim.”

Source: CourtListener parenthetical corpus (CC0).

Judges: Posner

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.